ArticleFrontiers in immunology2022

Combination of GD2-directed bispecific trifunctional antibody therapy with Pd-1 immune checkpoint blockade induces anti-neuroblastoma immunity in a syngeneic mouse model.

Sara Marie Ivasko et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.